Mr Deepak Hariharan

Mr Deepak Hariharan

MBBS, MD (Research), FRCS

Consultant General and Hepato-Pancreato-Biliary (HPB) Surgeon

Special Interests:

  • Gallstone disease
  • Primary Cancers of the Liver
  • Colorectal Liver Metastases and other Secondaries to Liver
  • Gallbladder and Bile duct cancer
  • Pancreatic cancer
  • Solid and cystic tumours of Pancreas
  • Pancreatitis
  • Laparoscopic Surgery
  • Abdominal wall Hernias / Groin hernias
LIPS Consultants Harley Street London
May 09 2023

Matthew Power Photography
www.matthewpowerphotography.co.uk
07969 088655
matthew@matthewpowerphotography.co.uk
@mpowerphoto

Synopsis

Mr Deepak sees patients privately at The Harley Street Clinic and The Princess Grace Hospital in Marylebone, both part of the HCA Group of hospitals. He remains active within the NHS and practices as a Consultant in HPB and General Surgery at the Royal London Hospital, part of Barts Health NHS Trust, one of the largest NHS Trusts in the country. Here, Deepak leads the weekly HPB Liver MDT and is Clinical Lead for HPB Services for the Barts Health NHS Trust and leads on HPB cancer – Diagnosis and Treatment for North East London Cancer Alliance.

His specialist interest includes treating all benign and malignant conditions affecting the liver, gallbladder, bile ducts and pancreas. He performs over 100 liver, pancreas and gallbladder resections each year.
He also has wider General Surgery Experience, both open and laparoscopic. He routinely undertakes laparotomies for control of sepsis and haemorrhage, bowel resections and abdominal wall hernia repair in both emergency and elective settings.

His clinical research interest has been to facilitate early diagnosis and treatment in HPB cancers. He investigated potential diagnostic biomarkers in urine for pancreatic cancer. His seminal paper established urinary proteomics as a strategy for the investigation of biomarkers for pancreas cancer. In September 2019, Pancreas Cancer Research Fund funded a £1.6M clinical study that would validate the accuracy and reliability of a urine test in detecting pancreatic cancer at an early stage.
He has multiple peer-reviewed publications in HPB and General Surgery and is a tutor and mentor to undergraduate, post-graduate trainees and nurses.

He is driven by quality improvement in surgery and is instrumental in setting up the Hot Cholecystectomy Pathway. This facilitates immediate/early gallbladder surgery for suitable cases presenting as an emergency with symptomatic gallstones. He helped establish an enhanced recovery programme after HPB cancer surgery to advance postoperative care.

He is motivated and focused on developing high-performing surgical teams to improve the quality of surgical care and enhance the patient experience.

History

Mr Deepak Hariharan was born in Bangalore, India and pursued undergraduate medical studies to qualify in 2001 from the Government Stanley Medical College and Hospital, Chennai, India.

He moved to the United Kingdom in 2002 to pursue postgraduate surgical training. He was awarded MD (Research) degree in 2008 following the completion of thesis looking for biomarkers of pancreas cancer in urine using proteomic strategies from the Queen Mary University of London.

 

He undertook Specialty General and HPB surgery training in the East Midlands at Queens Medical Centre, Nottingham, UK. He completed the FRCS exit examination in 2014 and was awarded Certificate of Completion of Training in 2016. He undertook subspecialty HPB surgery fellowships at HPB units at Queen Elizabeth Hospital, Birmingham, UK, Royal London Hospital, London, UK and Verona, Italy a dedicated and renowned Pancreas Cancer Centre.

He has been working as Consultant General and HPB Surgeon at the Royal London Hospital, London, the UK since 2018.

Annual Meeting, Birmingham, 2001; abstract published in BJS

Flutamide Suppresses VEGF Expression In The Hap-T1 Syrian Hamster Model Of Advanced Pancreatic Cancer

AT Abraham*, SR Shah, Y Sirivatanauksorn, BR Davidson *Patey Prize Session-ASGBI/SRS

IHPBA 2000 Amsterdam; abstract published in HPB

Flutamide Suppresses VEGf Expression In The Hap-T1 Syrian Hamster Model Of Advanced Pancreatic Cancer

AT Abraham, SR Shah, Y Sirivatanauksorn, BR Davidson

European IHPBA, Istanbul, May 2003; abstract published in HPB

Characterization Of The Endothelin System In The HaPT1 Syrian Hamster Model

AT Abraham, SR Shah, T Satyadas, J Tsui, M Dashwood, BR Davidson

ASGBI Manchester, May 2003 ‘Six of the Best Upper GI Papers’; abstract published in BJS

The Utility Of Whole Body FDG-PET In The Assessment Of Colorectal Liver Metastases: A Prospective Study

S Bhattacharya, AT Abraham*, RR Hutchins, C Desai, A McLean, JB Bomanji, DC Costa, PJ Ell

European IHPBA, Istanbul, May 2003; abstract published in HPB

The Utility Of Whole Body FDG-PET In The Assessment Of Colorectal Liver Metastases: A Prospective Study

S Bhattacharya, AT Abraham, RR Hutchins, C Desai, A McLean, JB Bomanji, DC Costa, PJ Ell

IHPBA, Edinburgh, September, 2006; abstract published in HPB

A Comparison of Pancreaticoduodenectomy with Extended Pancreaticoduodenectomy: A Meta-analysis of 1,421 Patients

N Iqbal ,R Lovegrove, HS Tilney, AT Abraham, S Bhattacharya, PP Tekkis, HM Kocher

IHPBA, Edinburgh, September, 2006; abstract published in HPB

Favourable Impact of COG and High Hospital Volume on Outcomes for Pancreatico-duodenectomy: A Single UK HPB Centre Experience

S Mukherjee, H Kocher, R Hutchins, S Bhattacharya, A Abraham

IHPBA, Edinburgh, September, 2006; abstract published in HPB

The Utility of Whole Body FDG-PET in the Assessment of Colorectal Liver Metastases Prior to Surgical Resection: A Prospective Study

D Hariharan, A Biswas, H Kocher, R Hutchins, S Bhattacharya, A Abraham

Poster presentation at the 7th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association, Seoul 2019

Surgical Challenges in Mirizzi’s Syndrome from Retained Cystic Duct – Common Bile Duct Junction Stones After Subtotal Cholecystectomy

Y L Wang, S L Oh, J Boo, A T Abraham, M Y Tan

AUGIS 2019

The use of POSSUM scoring and Cardiopulmonary exercise test are limited in predicting major complications after liver and pancreas surgery

De Braal VJF, Dutton J, Hariharan D, MacDonald N, Hallworth S, Kocher HM, Hutchins R, Imtiaz H, Bhattacharya S, Abraham A, Giakoustidis A, Yip VS

AUGIS 2019

Accuracy of pre-operative (P)-POSSUM scoring and cardiopulmonary exercise testing in predicting morbidity and mortality after pancreatic and liver surgery: A systematic review

Dutton J, De Braal VJF, Hariharan D, MacDonald N, Hallworth S, Kocher HM, Hutchins R, Imtiaz H, Bhattacharya S, Abraham A, Giakoustidis A, Yip VS

Indian Critical Care Guidelines 2019, Pune, India January 2019

Damage Control Surgery

Invited Speaker

Arab Health Congress, Dubai, January 2019

The Difficult Cholecystectomy / Hydatid Disease of the Liver

Invited Speaker

Back to Consultants

See Deepak's Publications